# Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)

> **NCT00832455** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 445 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** montelukast sodium

## Key facts

- **NCT ID:** NCT00832455
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 445 (ACTUAL)
- **Last updated:** 2024-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832455, "Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00832455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*